日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

利用诱导免疫原性细胞死亡的新策略来改善基于树突状细胞的淋巴瘤免疫治疗疫苗

B Montico, C Lapenta, M Ravo, D Martorelli, E Muraro, B Zeng, E Comaro, M Spada, S Donati, S M Santini, R Tarallo, G Giurato, F Rizzo, A Weisz, F Belardelli, R Dolcetti, J Dal Col

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

增强的自然杀伤细胞活性和保留的抗肿瘤CD8(+) T细胞反应有助于诱导接受新辅助化疗的HER2阳性乳腺癌患者达到病理完全缓解。

Muraro, E; Comaro, E; Talamini, R; Turchet, E; Miolo, G; Scalone, S; Militello, L; Lombardi, D; Spazzapan, S; Perin, T; Massarut, S; Crivellari, D; Dolcetti, Riccardo; Martorelli, D